Medikigai India Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.63 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.94 M
- Revenue Growth 825.47%
- Profit Growth 8905.68%
- Ebitda 6674.02%
- Net Worth 11.86%
- Total Assets 19.18%
About Medikigai India
Medikigai India Private Limited (MIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 17 October 2020 (Four years and three months 28 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.63 M.
The company has closed loans amounting to ₹2.94 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dhiren Kapadia and Radhika Kapadia serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U72900MH2020PTC348153
-
Company No.
348153
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Medikigai India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radhika Kapadia
|
Director | 17-Oct-2020 | Current |
|
Dhiren Kapadia
|
Director | 17-Oct-2020 | Current |
Financial Performance of Medikigai India.
Medikigai India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 825.47% increase. The company also saw a substantial improvement in profitability, with a 8905.68% increase in profit. The company's net worth Soared by an impressive increase of 11.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medikigai India?
In 2022, Medikigai India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹2.94 M
Charges Breakdown by Lending Institutions
- Others : 0.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2023 | Others | ₹2.94 M | Satisfied |
How Many Employees Work at Medikigai India?
Medikigai India has a workforce of 137 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medikigai India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medikigai India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.